Back to User profile » Dr Chaobin He
Papers published by Dr Chaobin He:
The Prognostic Significance of the CALLY Index in Ampullary Carcinoma: An Inflammation-Nutrition Retrospective Analysis
Xi P, Huang G, Huang K, Qin D, Yao Z, Jiang L, Zhu Q, He C
Journal of Inflammation Research 2025, 18:621-635
Published Date: 16 January 2025
Irreversible Electroporation Plus Anti-PD-1 Antibody versus Irreversible Electroporation Alone for Patients with Locally Advanced Pancreatic Cancer
He C, Sun S, Zhang Y, Li S
Journal of Inflammation Research 2021, 14:4795-4807
Published Date: 21 September 2021
An Inflammation-Index Signature Predicts Prognosis of Patients with Intrahepatic Cholangiocarcinoma After Curative Resection
He C, Zhao C, Zhang Y, Chen C, Lin X
Journal of Inflammation Research 2021, 14:1859-1872
Published Date: 11 May 2021
Identification of Circulating Biomarkers and Construction of a Prognostic Signature for Survival Prediction in Locally Advanced Pancreatic Cancer After Irreversible Electroporation
He C, Sun S, Zhang Y, Li S
Journal of Inflammation Research 2021, 14:1689-1699
Published Date: 28 April 2021
Integrated Bioinformatic Analysis of SARS-CoV-2 Infection Related Genes ACE2, BSG and TMPRSS2 in Aerodigestive Cancers
He C, Hua X, Sun S, Li S, Wang J, Huang X
Journal of Inflammation Research 2021, 14:791-802
Published Date: 10 March 2021
Development and validation of a nomogram to predict liver metastasis in patients with pancreatic ductal adenocarcinoma: a large cohort study
He C, Zhong L, Zhang Y, Cai Z, Lin X
Cancer Management and Research 2019, 11:3981-3991
Published Date: 2 May 2019
The prognostic and predictive value of the combination of the neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio in patients with hepatocellular carcinoma who receive transarterial chemoembolization therapy
He C, Zhang Y, Cai Z, Lin X
Cancer Management and Research 2019, 11:1391-1400
Published Date: 12 February 2019